ARA says no to medical cannabis

The Australian Rheumatology Association says it will not recommend medical cannabis as a treatment for chronic musculoskeletal pain except in the context of a clinical trial.

In a new position statement, the ARA says evidence from high-quality randomised controlled trials is needed before medical cannabis can be integrated into clinical practice.

It also says any clinical evidence for efficacy must be weighed against potential harms